NCT06225882View on ClinicalTrials.gov

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

December 31, 2026

Conditions
Patients With PH1 Treated With Lumasiran in France
Interventions
DRUG

Oxaluria evolution.

To collect real data from the specific French experience by collecting data from patients treated throughout the country and to monitor in particular the evolution of oxaluria before and after treatment.

Trial Locations (7)

13385

RECRUITING

AP-HM - Timone Enfants, Marseille

25030

RECRUITING

CHU de Besançon, Besançon

69003

RECRUITING

Hopital Edouard Herriot, Lyon

69500

RECRUITING

Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant, Bron

75015

RECRUITING

Hôpital Européen G. Pompidou, Paris

RECRUITING

Hôpital Necker, APHP Paris, Service de néphrologie-dialyse, 149 rue de Sèvres, Paris

75743

RECRUITING

CHU Paris - Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER